Position in PFE
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$53,695,530
-$86,487,087 QoQ
Shares Held
1,912,234
-66.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Jun 30, 2022CallValue
$5,400
CallShares
103
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NATIXIS holds $547,855,762 across 11 Drug Manufacturers - General names. PFE ranks #5 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
2,068,064 | $125,428,081 | |
| 2 | LLY |
ELI LILLY & Co
|
100,947 | $92,848,022 | |
| 3 | NVO |
Novo Nordisk A S
|
2,005,285 | $73,694,223 | |
| 4 | MRK |
Merck & Co., Inc.
|
510,056 | $61,354,636 | |
| 5 | PFE |
Pfizer Inc
This page
|
1,912,234 | $53,695,530 | |
| 6 | JNJ |
Johnson & Johnson
|
213,825 | $52,267,383 | |
| 7 | ABBV |
AbbVie Inc.
|
233,196 | $50,717,798 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
156,715 | $21,841,369 |
All Filings in PFE
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $53,695,530 | 1,912,234 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $140,182,617 | 5,629,824 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $84,749,231 | 3,326,108 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $45,966,215 | 1,896,296 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $71,110,020 | 2,806,236 | Shares | Sole | 2025-07-18 | |
| 2024-12-31 | $139,982,785 | 5,276,396 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $52,535,418 | 1,815,322 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $39,108,708 | 1,397,738 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $79,834,002 | 2,876,901 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $52,324,817 | 1,817,465 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $34,643,908 | 1,044,435 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $44,491,482 | 1,212,963 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $54,874,653 | 1,344,967 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $155,327,449 | 3,031,371 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $0 | 0 | Call | Sole | 2022-11-14 | |
| 2022-09-30 | $120,557,311 | 2,754,966 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $0 | 0 | Put | Sole | 2022-08-12 | |
| 2022-06-30 | $5,400 | 103 | Call | Sole | 2022-08-12 | |
| 2022-06-30 | $127,146,839 | 2,425,078 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $75,194,371 | 1,452,470 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $87,941,688 | 1,489,275 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $127,333,685 | 2,960,560 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $227,142,685 | 5,800,375 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $50,194,563 | 1,385,442 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $169,853,450 | 4,614,329 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $132,819,049 | 3,814,480 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $18,841,548 | 607,308 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $103,843,121 | 3,353,272 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||